| Value | ₹14.63 Cr |
|---|
NSE filing, NSE: GSMFOILS. Summary written from the filing by ALFA Finder's alert engine.
GSM Foils Ltd: key numbers
- Share price
- ₹58.60
- Market cap
- ₹82.58 Cr
- Revenue (annual)
- ₹258.1 Cr
- Net profit (annual)
- ₹19.84 Cr
- P/E (TTM)
- 4.2×Sector 46.8×
- Promoter holding
- 54.38%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GSM Foils Ltd
All →GSM Foils Other Announcement
GSM Foils received a further three-month ROC extension, to December 31, 2026, for holding its FY2026 AGM. The AGM date will be intimated after board approval.
GSM Foils Business Update
GSM Foils reported net sales of Rs. 13.29 Crore for September 2026. This disclosure provides monthly operational sales performance figures to the exchange.
GSM Foils Other Announcement
GSM Foils Limited received approval from the Registrar of Companies to extend its Annual General Meeting deadline for FY2026 by 1.5 months to November 15, 2026.
GSM Foils Management Change
GSM Foils Limited has appointed Ms. Riya Dinanath Devulkar as Company Secretary and Compliance Officer, effective September 11, 2026.
GSM Foils Board Meeting Outcome
GSM Foils Limited appointed Ms. Riya Dinanath Devulkar as the Company Secretary and Compliance Officer, effective September 11, 2026.
GSM Foils Business Update
GSM Foils Limited reported net sales of ₹10.71 Crore for August 2026. This monthly business update provides key sales performance data for investors.
- Value
- ₹10.71 Cr
Other business update announcements
All →Fino Payments Bank Business Update
Fino Payments Bank's October 2026 update showed deposits crossing Rs 3,000 Crore for the first time. Loan referral disbursals rose 316% year-on-year to Rs 301 Crore.
Ugar Sugar Works Business Update
Ugar Sugar Works has informed the exchanges that crushing for the 2026-27 season started at its Ugar Unit on 06 Nov 2026. Crushing will ramp up to full capacity over time.
Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
Runwal Enterprises Business Update
Runwal Enterprises adopted a fair disclosure code for unpublished price sensitive information under SEBI PIT Regulation 8. The code is hosted on the company website.
Mphasis Business Update
Mphasis's board approved amendments to its Code of Practices and Procedures for Fair Disclosure of UPSI. The amended code is published on the company website.
Kingfa Science & Technology (India) Business Update
Kingfa Science & Technology filed a Q2 FY2026-27 performance update deck with greetings, market outlook and industry auto-production data. No revenue/profit table, order, or transaction is disclosed, so it is routine investor material.